Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs

CMAJ. Canadian Medical Association Journal

Volumn 181, Issue 9, 2009, Pages 585-589

  DeBeck, Kora ^a   Kerr, Thomas ^a   Li, Kathy ^a   Fischer, Benedikt ^b   Buxton, Jane ^a   Montaner, Julio ^a   Wood, Evan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROCONVERSION; SMOKING HABIT; SOCIAL NETWORK;

ADULT; AGE DISTRIBUTION; BRITISH COLUMBIA; COCAINE-RELATED DISORDERS; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; CRACK COCAINE; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; SEX DISTRIBUTION; SUBSTANCE ABUSE, INTRAVENOUS; SURVIVAL ANALYSIS; URBAN POPULATION; YOUNG ADULT;

EID: 70449561022     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.082054     Document Type: Article

References (25)

1. Public Health Agency of Canada. HIV and AIDS in Canada. Surveillance report to December 31, 2006. Ottawa (ON): Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; 2007.
2. Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003;17:887-893 (Pubitemid 36547661)
3. Fischer B, Rehm J, Patra J, et al. Changes in illicit opioid use across Canada. CMAJ 2006;175:1385. (Pubitemid 44876556)
4. Fairbairn N, Kerr T, Buxton JA, et al. Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting. Drug Alcohol Depend 2007;88:313-316 (Pubitemid 46482828)
5. Leonard L, DeRubeis E, Pelude L, et al. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. Int J Drug Policy 2008;19:255-264 (Pubitemid 351698121)
6. Haydon E, Fischer B. Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits.' Can J Public Health 2005;96:185-188
7. Public Health Agency of Canada. I-Track: enhanced surveillance of risk behaviours among injecting drug users in Canada [pilot survey report]. Ottawa (ON): Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; 2004. Available: www.phac-aspc.gc.ca/i-track /index-psr-rep04-eng.php (accessed 2009 July 23).
8. Fischer B, Rehm J, Brissette S, et al. Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health 2005;82:250-266 (Pubitemid 41214941)
9. Edlin BR, Irwin KL, Faruque S, et al. Intersecting epidemics - crack cocaine use and HIV infection among inner-city young adults. N Engl J Med 1994;331:1422-1427 (Pubitemid 24984729)
10. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 2009;338:b1649.
11. Fischer B, Rehm J, Patra J, et al. Crack across Canada: comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction 2006;101:1760-1770 (Pubitemid 44899698)
12. Wood E, Lloyd-Smith E, Li K, et al. Frequent needle exchange use and HIV incidence in Vancouver, Canada. Am J Med 2007;120:172-179 (Pubitemid 46175770)
13. Law CG, Brookmeyer R. Effects of mid-point imputation on the analysis of doubly censored data. Stat Med 1992;11:1569-1578
14. Spittal PM, Craib KJ, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ 2002;166:894-899 (Pubitemid 34275509)
15. Kuyper LM, Lampinen TM, Li K, et al. Factors associated with sex trade involvement among male participants in a prospective study of injection drug users. Sex Transm Infect 2004;80:531-535 (Pubitemid 39627263)
16. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989;321:874-879 (Pubitemid 19238620)
17. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York (NY): Springer; 2000.
18. Porter J, Bonilla L, Drucker E. Methods of smoking crack as a potential risk factor for HIV infection: crack smokers' perceptions and behavior. Contemp Drug Probl 1997;24:319-347 (Pubitemid 127106366)
19. Latkin CA, Mandell W, Vlahov D. The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. Drug Alcohol Depend 1996;42:175-181 (Pubitemid 26356551)
20. Shannon K, Ishida T, Morgan R, et al. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduct J 2006;3:1. (Pubitemid 43103514)
21. Malchy L, Bungay V, Johnson J. Documenting practices and perceptions of 'safer' crack use: a Canadian pilot study. Int J Drug Policy 2008;19:339-341
22. Hedrich D. European report on drug consumption rooms. Luxembourg City (Luxembourg): European Monitoring Centre for Drugs and Drug Addiction; 2004. Available: www.emcdda.europa.eu/attachements.cfm/att-2944-EN-consumption-rooms- report.pdf (accessed 2009 July 23).
23. Collins CL, Kerr T, Kuyper LM, et al. Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use. J Urban Health 2005;82:276-284 (Pubitemid 41214943)
24. Tyndall MW, Craib KJ, Currie S, et al. Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr 2001;28:351-357 (Pubitemid 33101288)
25. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993;88:517-526 (Pubitemid 23115920)